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ABSTRACT
Background: in 21st century, endoscopic study of the small
intestine has undergone a revolution with capsule endoscopy and
balloon-assisted enteroscopy. The difficulties and morbidity asso-
ciated with intraoperative enteroscopy, the gold-standard in the
20th century, made this technique to be relegated to a second level. 
Aims: evaluate the actual role and assess the diagnostic and
therapeutic value of intraoperative enteroscopy in patients with
obscure gastrointestinal bleeding. 
Patients and methods: we conducted a retrospective study
of 19 patients (11 males; mean age: 66.5 ± 15.3 years) submitted
to 21 IOE procedures for obscure GI bleeding. Capsule endoscopy
and double balloon enteroscopy had been performed in 10 and 5
patients, respectively.
Results: with intraoperative enteroscopy a small bowel bleeding
lesion was identified in 79% of patients and a gastrointestinal bleed -
ing lesion in 94%. Small bowel findings included: angiodysplasia
(n = 6), ulcers (n = 4), small bowel Dieulafoy’s lesion (n = 2), bleed -
ing from anastomotic vessels (n = 1), multiple cavernous heman-
giomas (n = 1) and bleeding ectopic jejunal varices (n = 1). Agree -
ment between capsule endoscopy and intraoperative enteroscopy
was 70%. Endoscopic and/or surgical treatment was used in 77.8%
of the patients with a positive finding on intraoperative enteroscopy,
with a rebleeding rate of 21.4% in a mean 21-month follow-up
period. Procedure-related mortality and postoperative complications
have been 5 and 21%, respectively. 
Conclusions: intraoperative enteroscopy remains a valuable
tool in selected patients with obscure GI bleeding, achieving a high
diagnostic yield and allowing an endoscopic and/or surgical treat-
ment in most of them. However, as an invasive procedure with
relevant mortality and morbidity, a precise indication for its use is
indispensable.
Key words: Enteroscopy. Intraoperative enteroscopy. Small bowel.
Endoscopy. GI obscure bleeding.
INTRODUCTION
Gastrointestinal (GI) bleeding is one of the most common
problems seen by gastroenterologists. The source of bleed-
ing can be identified in most cases by conventional
endoscopy, but approximately 5% of all remain undiag-
nosed (1,2). This type of bleeding is named obscure GI
bleeding (OGIB) and is defined as bleeding of unknown
origin that persists or recurs after a negative initial upper-
GI and lower-GI endoscopy. It can be classified in obscure
overt and obscure occult bleeding taking into account the
presence or absence of clinically evident bleeding. Because
OGIB is frequently due to a lesion in the small bowel it is
also known as mid-gut bleeding (3). 
In the past, endoscopic conventional methods for small
intestine study were sonde-type enteroscopy and push-type
enteroscopy. However, if sonde-type enteroscopy has been
rarely used in clinical practice (4,5), push-type enteroscopy
only allows the examination of the proximal small bowel
with a reported diagnostic yield for OGIB between 45-78%
(6-8). As a result, in 20th century, intraoperative enteroscopy
(IOE) was the gold standard for detection of lesions in the
small bowel, allowing the exploration of the entire mucosa.
It was in 1976 that fiber-optic endoscopes where first time
used intraoperatively (9). Since then, IOE became available
as a feasible alternative, with a high diagnostic yield in
patients with OGIB (10). The standard procedure technique
consists of a laparotomy followed by the insertion of a stan-
dard colonoscope (if possible pediatric), an enteroscope or
even a standard gastroscope, through a small enterotomy.
A per-orally and/or per-rectum technique can also been uti-
lized.
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With the introduction of wireless capsule endoscopy
(CE) (M2A; Given Imaging Ltd, Yoqneam, Israel) in 2000,
a new era in GI imaging began (11,12). Recognized its supe-
riority over the other endoscopic methods, it became the
first-line, noninvasive, diagnostic technique for the small
bowel (13-18). Despite this incontestable progress, it was
expected the development a new endoscopic device that
would complement the inability to collect biopsies or per-
form therapy with CE. In 2001, Yamamoto et al. published
their experience with double balloon enteroscopy (DBE)
(19,20). The superiority and utility of DBE for the diagnosis
and therapy of small-bowel disorders has been demonstrat-
ed in several studies, with diagnostic yields varying between
25 and 92% (10). Compared to push-enteroscopy the diag-
nostic yield in OGIB was 73 versus 44% (21). A single bal-
loon enteroscope and a spiral overtube enteroscope have
been recently developed. Single-balloon enteroscopy per-
formance and diagnostic yield was comparable to DBE,
whereas spiral enteroscopy showed a reduction in the exam-
ination time (22-26). 
Balloon-assisted enteroscopy is now considered the stan-
dard technique for endoscopic visualization of the small bow-
el. However, although it was judged that IOE would
be excluded as a diagnostic and therapeutic procedure, there
are some cases where balloon-assisted enteroscopy cannot
be performed, where it investigates only partially the small
bowel or where it cannot achieve endoscopic treatment. In
that cases IOE is useful, providing complete endoscopic
assessment of entire small intestine, exact detection and local-
ization of extramural and/or luminal lesions with definitive
surgical and/or endoscopic therapy during the same session. 
The aim of our study was to evaluate the actual role of
IOE and to assess its diagnostic and therapeutic value in
patients with OGIB, in a third referral center.
PATIENTS AND METHODS
This is a retrospective, descriptive study, involving all
patients submitted to IOE for OGIB, between 2000 and 2010.
Patients were identified by use of coding software to search
the medical record database. In this period, 20 consecutive
patients submitted to IOE were identified: 19 for diagnosis
and treatment of OGIB and 1 for planned polypectomy in
Peutz-Jeghers syndrome. The 19 patients (11 males; mean
age: 66.5 ± 15.3 years, range: 29-86) submitted to 21 IOE
procedures for OGIB, comprised the final patient sample.
Their charts were analyzed retrospectively regarding demo-
graphic, clinical and laboratory data. Evaluation focused on
type of bleeding (overt or obscure), duration of gastrointesti-
nal bleeding, previous investigations (endoscopic and radi-
ological), transfusion requirements before and after the pro-
cedure, endoscopic findings and their location, agreement
rate between IOE and DBE or CE, endoscopic and/or surgical
therapeutic procedures, final histopathological results of sur-
gical specimens, rebleeding rate, complications of IOE, time
of follow-up and mortality. The main outcome measurements
were diagnostic accuracy, therapeutic efficacy, rebleeding
rate and complications. Patient follow-up was based on out-
patient consultations registers and telephone interviews. All
patients were submitted to extensive preoperative evaluation,
and some underwent CE and/or DBE that were introduced
in our hospital in 2001 and 2005, respectively.
Intraoperative enteroscopy was performed by a team of
surgeons and gastroenterologists. After a median laparotomy,
adhesiolysis was performed and the small intestine was
explored. If no source of OGIB was identified the endoscope
was introduced via a transoral and/or transanal route or by
a mid-small bowel enterotomy. Each approach took into con-
sideration the findings of VCE, when it was performed prior
to IOE. The first enteroscopies were done using conventional
colonoscope or gastroscope. The latter enteroscopies were
performed using a Fujinon FN450-P5/20 enteroscope (Fuji-
non Inc, Japan), 200-cm working length, without overtube-
balloon equipment. If the transoral route was adopted, after
a new investigation of upper digestive tract the endoscope
was pushed forward into the jejunum, facilitated with duo-
denum mobilization by the surgeon, and continued through
the small intestine, as far as possible, helped by the surgeon
that pleated the small intestine over endoscope. If an entero-
tomy was necessary, the surgeon prepared the small bowel
enterotomy and then placed the endoscope through a sterile
sleeve in the intestinal lumen. The endoscope was then
pushed up to the duodenum and next down to the cecum.
Room air as insufflation agent was used. In IOE, although
the gastroenterologist operates the endoscope, the insertion
and withdraw of the endoscope is performed by the surgeon,
therefore it is necessary a perfect collaboration of both. The
mucosa was cautiously observed during insertion of endo-
scope, because of trauma induced by intubation and bowel
manipulation could be wrongly confounded with angiectasias
upon withdrawal of the endoscope. If a lesion or bleeding
source was detected, endoscopic (argon plasma coagulation)
or surgical treatment was performed in the same surgical ses-
sion if necessary. Informed consent was obtained from all
patients and/or their parents for all procedures.
Continuous variables were expressed as mean with stan-
dard deviation and range. Categorical variables were ex -
pressed with percentage. Statistical analysis of data was per-
formed using Statistical Package for Social Sciences (SPSS)
version 16.0 for Windows (SPSS, Inc., Chicago, USA).
RESULTS
Of the 19 patients submitted to IOE for evaluation of
OGIB, 17 (89%) presented with obscure overt bleeding
(i.e, melena or hematoquezia) and 2 (11%) with obscure
occult bleeding. On average, the mean duration of OGIB
history was 3.3 ± 6.4 months (range: 0-24) and a mean of
17.5 ± 18.9 (range: 2-50) blood units were transfused pre-
operatively (Table I). All patients underwent at least one
upper and lower endoscopy, previous to IOE. Capsule
endoscopy and DBE had been performed in 10 (53%) and
5 (26%) patients, respectively. When performed, DBE was
preceded by VCE in all cases.  Nine patients were referred
directly to IOE without previous DBE or VCE: in 3 because
these exams had not been introduced yet in our Digestive
Endoscopy Unit and in 6 because it was not possible to per-
form emergent VCE or DBE and the clinical situation need-
ed urgent resolution. The modalities of preoperative diag-
nostic evaluation of OGIB are listed in table II. 
In total, 21 IOE were performed (one patient required 3
IOE). They were done by transoral approach exclusively
(n = 6), by combined transoral and transanal approaches
(n = 2) or transparietal with enterotomy (n = 13), however,
in two of these cases an additional enterotomy was required
to avoid overdistension of the mesentery.
A gastroscope or colonoscope was used in 11 procedures
and a 200 cm working length enteroscope in 10. The entire
exploration of small intestine was possible in 63% of
patients. In fact, in the 6 patients where was used exclusively
the transoral approach, only in 3 (50%) the total length of
the intestine was explored. This was due to the fact that a
lesion or bleeding source has already been detected in the
explored segment, making unnecessary extending the pro-
cedure. In the same way, of the 11 patients where was used
an enterotomy approach, only in 2 (18%) the ileum was
explored: in one case to evaluate the terminal ileum and an
enterocolic anastomosis and in other case to assess a bleed-
ing subepithelial lesion previously identified in CE.
Endoscopic findings
A small bowel bleeding lesion was identified in 15 (79%)
patients. However, despite no small intestine lesion was
found in 4 (21%) patients, in 3 of them the IOE identified
an outside small intestine source of bleeding. So, the diag-
nostic yield of IOE, for OGIB lesions, was 94% (18/19
patients). 
The leading intra-operative endoscopic findings includ-
ed angiodysplasia in 6 (32%) and ulcers in 4 (21%)
patients. The etiology of ulcerative lesions was attributed
to non-steroidal anti-inflammatory drugs (n = 2),
cytomegalovirus enteritis (n = 1) and chronic small bowel
ischemia (n = 1). The other findings were small bowel
Dieulafoy’s lesion (n = 2), bleeding from anastomotic ves-
sels after ileocolic resection (n = 1), multiple cavernous
hemangiomas (n = 1) (Figs. 1-5) and bleeding ectopic
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Table I. Demographic and clinical history  
n / Mean ± SD Range
Patients 19 –
Male/Female 11/8 –
Age (years) 66.5 ± 15.3 29-86
Mean blood transfusions (units) 17.5 ± 18.9 2-50






Mesenteric arteriography 11 (58%)
99mTc-labeled RBC radionuclide study 6 (32%)
Entero CT scan 2 (11%)
Small bowel contrast study 1 (5%) Fig. 2. Intraoperative enteroscopy: two cavernous hemangiomas at the
jejunum.
Fig. 1. Video capsule endoscopy: active bleeding cavernous hemangioma
in the jejunum.
jejunal varices (n = 1). In 4 (21%) patients no small bowel
lesion was identified, however a colonic diverticular
bleeding, a duodenal angiodysplasia and a duodenal ulcer
were detected under IOE and assumed as the source of
the bleeding (Table III).
Comparison with CE and DBE
Ten patients were submitted to CE. The capsule reached
the cecum at the end of the procedure in all procedures and
allowed the entire visualization of the small bowel. Agree-
ment with IOE was 70%, with discordant findings in 3 cas-
es: in case no. 1 CE visualized one subepithelial small bow-
el lesion that was not recognized in IOE; in case no. 2 CE
visualized one jejunal angiodysplasia but IOE only identi-
fied a duodenal angiodysplasia; in case no. 3 CE visualized
a subepithelial bleeding lesion that IOE confirmed to be a
bleeding angiodysplasia.
Five patients underwent DBE. The reasons to perform
IOE in these patients were: incomplete investigation of the
small bowel (3), unsuccessful endoscopic treatment with
major bleeding (1), and precise localization and definitive
surgical treatment of a small bowel lesion (1). In patients
in whom IOE and DBE explored the same intestinal seg-
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Fig. 4. Surgical specimen: two cavernous hemangiomas at the jejunum.
Table III. Diagnostic and procedures of IOE 
Lesions n Endoscopic Surgical 
(19) procedure procedure
Small bowel 6 APC (2) Segmental resection (5)
angiodysplasia
Ulcers 4
NSAIDs 2 – Segmental resection (2)
Cytomegalovirus 
enteritis 1 – –
Chronic small bowel 
ischemia 1 – –
Dieulafoy’s lesion 2 – Segmental resection (2)
Bleeding from anastomotic 1 - Reanastomosis (1)
vessels
Cavernous hemangiomas 1 - Segmental resection (1)
Bleeding ectopic jejunal 1 - Segmental resection (1)
varices
Normal small bowel finding 4 –
Colonic diverticular – Colonic resection (1)
bleeding 1
Duodenal angiodysplasia 1 – –
Duodenal ulcer 1 – –
APC: argon plasma coagulation. NSAIDs: nonsteroidal anti-inflammatory drugs.Fig. 5. Surgical specimen: one cavernous hemangioma at the ileon. 
Fig. 3. Intraoperative enteroscopy: one cavernous hemangioma at the
ileon.
ments there were no discordant findings. Also of note, after
the introduction of DBE, the number of patients submitted
to IOE increased from 1.3 to 2.2/year.
Therapy performed
Of the 18 patients with a positive finding on IOE, 14
(77.8%) were submitted to endoscopic (1/14, 7.1%), sur-
gical treatment (12/14, 85.8%) or a combined approach
(1/14, 7.1%). Argon-plasma coagulation was used in
2 patients. Segmental resection was performed in 11 pa -
tients, a reanastomosis in one and a colonic resection in
another (Table III).
Morbidity, mortality and long-term results
Six patients (31.6%) died after a mean follow-up period
of 21 ± 24 months (1-72). Mortality associated to IOE was
5%: one patient developed postoperative cardiovascular
complications and died after cardiac arrest within 24 hours
after IOE. Of the remaining 5 patients, 3 died in relation
with small bowel disease (cytomegalovirus enteritis, chronic
small bowel ischemia and rebleeding from small bowel
angiodysplasia). 
Of the patients submitted to endoscopic and/or surgical
treatment, rebleeding occurred in 21.4% (3/14): small bowel
angiodysplasia treated endoscopically (1), development of
new ectopic jejunal varices (1) and rebleeding from anas-
tomotic vessels (1). Overall rebleeding rate was 26.3%.
Postoperative complications included prolonged ileus (2
patients) and adverse cardiovascular events (2 patients).
DISCUSSION 
In the beginning of 21st century, CE and balloon-assisted
enteroscopy revolutionized the endoscopic exploration of
the small intestine, particularly in the management of OGIB.
Capsule endoscopy is now the preferred method of evalu-
ation because it is noninvasive, well-tolerated, allows the
entire examination of small bowel and provides an approx-
imate localization of the site of the bleeding, guiding further
investigations and treatments. Balloon-assisted enteroscopy
is considered the second-line examination for patients with
OGIB and positive findings in CE requiring further explo-
ration or therapeutic intervention(10,27). However, the
reported rates of total small bowel intubation vary widely
(ranging from 0 to 86%), hampered by the presence of
intestinal adhesions of previous surgery, obesity or with
operators with less experience (19,20,23,25,28-30). Nev-
ertheless, when balloon enteroscopy approach is directed
by CE findings, one-side procedure was sufficient to
achieve the lesion in almost 90% of examinations (31). 
Due to these new developments, indications of IOE have
decreased during last years. It is now used as the ultimate
procedure in patients where balloon-assisted enteroscopy
cannot be performed or fails to investigate the entire small
bowel and to achieve a definitive treatment. Curiously, in
our center, the number of IOE procedures has increased
after the implementation of DBE. This perhaps may be
explained by a better accuracy in the diagnosis of mid-gut
bleeding with the new endoscopic (CE and DBE) and imag-
ing (CT, angiography) techniques, remaining the IOE as a
last choice, namely during emergent situations when DBE
was unavailable.
The main drawback of IOE is the need of laparotomy or
laparoscopy, with inherent risk of adhesions formation, per-
foration, abdominal and wound infections and ventral her-
nias. Besides surgical morbidity, other complications
include serosal tears, avulsion of mesenteric veins, pro-
longed ileus and cardiovascular events during convales-
cence period. It has the advantage of making possible the
evaluation of all small intestine, providing a immediate sur-
gical resolution of pathological findings. In fact, the rate
of complete enteroscopy with IOE is superior to balloon-
assisted enteroscopy, ranging between 57 and 100% in most
series (32-41). In our series IOE was able to explore the
complete small intestine in 63% of patients: 50% in per-
oral approach versus 82% in enterotomy approach. Many
reports attest the failure to reach the terminal ileum in a
considerable number of patients in the per-oral approach,
as the limited work length of the endoscopes doesn’t permit
a complete inspection of small bowel (34,36,37). 
The ability of IOE to identify small bowel lesions has
been remarkable, ranging between 70 to 100%, allowing a
therapeutic procedure in 40 to 100% of these cases, with a
recurrent bleeding rate between 6 to 52% (32-41). This is
also reflected in our results where IOE was diagnostic in
94% of the cases (18/19), allowing a endoscopic and/or
surgical therapeutic procedure in 77.8% (14/18), with a
rebleeding rate of 21.4% (3/14). In 3 patients a duodenal
or colonic source of bleeding was identified during IOE.
The reasons why these lesions have been missed by upper-
GI or lower-GI endoscopy are unclear. Nevertheless, in 7
to 24% of patients with OGIB that perform an small intes-
tine study with CE or DBE, the source of blood loss is found
in the stomach or the colon, within reach of conventional
endoscopy (42-44). The most common findings by IOE
were vascular lesions (angiodysplasia and Dieulafoy’s
lesion) and ulcers. These are typical potential causes of
OGIB in older patients, in accordance to the age sample of
our series. The ability of IOE to identify a lesion and allow
a definitive treatment was 77.8% (14/18): 1 was treated
endoscopically with argon plasma coagulation, 12 were
submitted to surgical treatment and 1 by a combined sur-
gical and endoscopic approach. The other 4 patients did
not require or was not indicated any intraoperative treat-
ment. As in other series, surgery was the most frequently
employed modality, taking advantage of the fact that on the
other side of the small bowel worked a surgeon. Surgical
treatment can grant definitive resolution and lower rates of
rebleeding. Although the time of follow-up has not been
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extensive, taking into account just the patients submitted
endoscopic and/or surgical treatment, the rebleeding rate
was 21.4%, similar to other series values (32-41). In fact,
rebleeding is the main problem arising from the manage-
ment of OGIB. Vascular diseases such as angiodysplasia
are more likely to rebleed than nonvascular diseases, but
surgically treated patients had lower frequency of rebleeding
rate than patients submitted to medical or endoscopic treat-
ment (28,45). Other potentially causes of rebleeding are
incomplete surgical resection in a multifocal intestine
involvement or postoperative development of new lesions
in other spared segments (32). 
Ten patients underwent CE previously to IOE. In patients
in whom IOE and DBE explored the same intestinal seg-
ments there were discordant findings in 3 cases, as
described above. CE has been previously compared with
IOE in patients with OGIB. CE had sensitivity, specificity
and positive and negative predictive values of 95, 75, 95
and 86%, respectively with an agreement rate with IOE in
93% of the cases (41). In our series, agreement between
CE with IOE was good, achieving a value of 70%. 
The main disadvantage of IOE over other techniques is
his surgical morbidity and non-negligible associated mor-
tality rate. Procedure-related mortality and postoperative
complications have been 5 and 21%, respectively, and
although most studies report a low procedure-related mor-
tality, it has been up 17% in some series (32-41). This main
disadvantage, associated to the development of new deep
enteroscopy modalities, had relegated this technique as a
last option in the management of OGIB. In fact, after the
introduction of assisted-balloon enteroscopy in our center,
90 patients with OGIB were managed with DBE and only
11 with IOE. However, in our series, five patients under-
went IOE after an initial DBE, pointing out that IOE can
complement balloon-assisted enteroscopy in some precise
indications.
In conclusion, although IOE remains useful in the man-
agement of OGIB, achieving a diagnostic yield of 94% and
allowing a definitive treatment in 77.8%, it should be
reserved for patients with massive, continuous or recurrent
gastrointestinal bleeding when other less invasive methods
have failed to treat the source of hemorrhage or were unable
to complete the investigation of the small bowel.
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